ZBNA
TBPH icon

Zions Bancorporation, National Association’s Theravance Biopharma TBPH Stock Holding History

Zions Bancorporation, National Association’s Portfolio TBPH Stock Details TBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$255 Hold
15
– – ﹤0.01% 1592
2026
Q1 		$243 Buy
+15
New +$265 ﹤0.01% 1512

Other funds holding TBPH

CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
SSA
Sierra Summit Advisors Incline Village, Nevada $895M AUM 106% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
JWS
Juncture Wealth Strategies Scottsdale, Arizona $384M AUM 27.62% 1-Year Est. Return
DAM
Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return
JIR
James Investment Research Alpha, Ohio $984M AUM 36.03% 1-Year Est. Return
BP
Ballentine Partners Waltham, Massachusetts $8.18B AUM 27.59% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Zions Bancorporation, National Association's TBPH Position: Q2 2026 in Review

Zions Bancorporation, National Association held its Theravance Biopharma (TBPH) position steady in Q2 2026 at 15 shares worth $255. The position accounts for ﹤0.01% of the portfolio, ranked #1592.

Zions Bancorporation, National Association first reported a position in TBPH in Q1 2026 and has held it in 2 quarters since. 31 funds tracked by Wall St. Rank hold TBPH as of Q2 2026.

  • Zions Bancorporation, National Association held 15 shares of Theravance Biopharma worth $255 as of Q2 2026.
  • Zions Bancorporation, National Association left its Theravance Biopharma share count unchanged in Q2 2026.
  • Theravance Biopharma made up ﹤0.01% of Zions Bancorporation, National Association's portfolio in Q2 2026, its #1592 holding.
  • Zions Bancorporation, National Association first reported a position in Theravance Biopharma in Q1 2026 and has held it in 2 quarters since.
  • 31 funds tracked by Wall St. Rank held Theravance Biopharma as of Q2 2026.

Based on Zions Bancorporation, National Association's 13F filing for Q2 2026, filed 31 Jul 2026.